CATEGORY

Parkinson’s disease

Parkinson’s disease is a progressive neurodegenerative disease that usually develops at 40–70 years of age, with major signs of dyskinesia […]

Read more

Amyotrophic Lateral Sclerosis(ALS)

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that selectively affects motor neurons and has no known cause or treatment. […]

Read more

Alzheimer’s disease

We incorporate the gene that encodes an enzyme that decomposes amyloid-β peptides (Aβ) into a virus vector that only expresses […]

Read more

Molecular Imaging

To complement the gene therapy, we are applying molecular imaging technology to diagnose symptoms and to evaluate the effects of […]

Read more

AAV vector platform

Broad intellectual property around two original AAV vectors (AAV.GTX and AAV.GT5) with in vivo proof of concept data Potential out-licensing […]

Read more

In-house Manufacturing Facility

Two years of gene therapy manufacturing expertise First GCTP/cGMP/PICS GMP complied manufacturing facility with 200L bioreactor completed Mar 2017 The […]

Read more